MCM
MEDP icon

Manchester Capital Management’s Medpace MEDP Stock Holding History

Manchester Capital Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1
Closed -$481 – 1342
2026
Q1 		$481 Hold
1
– – ﹤0.01% 1238
2025
Q4 		$562 Hold
1
– – ﹤0.01% 1248
2025
Q3 		$515 Hold
1
– – ﹤0.01% 1199
2025
Q2 		$314 Hold
1
– – ﹤0.01% 1145
2025
Q1 		$305 Hold
1
– – ﹤0.01% 1108
2024
Q4 		$333 Hold
1
– – ﹤0.01% 1101
2024
Q3 		$334 Sell
1
-506
-100% -$192K ﹤0.01% 1109
2024
Q2 		$209K Hold
507
– – 0.03% 302
2024
Q1 		$205K Buy
507
+506
+50,600% +$178K 0.03% 308
2023
Q4 		$307 Buy
+1
New +$270 ﹤0.01% 952
2022
Q3 		– Sell
-56
Closed -$8K – 960
2022
Q2 		$8K Hold
56
– – ﹤0.01% 511
2022
Q1 		$9K Sell
56
-54
-49% -$8.9K ﹤0.01% 555
2021
Q4 		$24K Hold
110
– – ﹤0.01% 466
2021
Q3 		$21K Buy
+110
New +$20.1K ﹤0.01% 514

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Manchester Capital Management's MEDP Position: Q2 2026 in Review

Manchester Capital Management sold out of Medpace (MEDP) in Q2 2026, closing a stake of 1 share — an estimated $481 sold.

Manchester Capital Management first reported a position in MEDP in Q3 2021 and held it in 14 quarters. The position peaked at $209K in Q2 2024. 698 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Manchester Capital Management reported no remaining Medpace position as of Q2 2026 after selling out during the quarter.
  • Manchester Capital Management sold 1 Medpace share in Q2 2026, an estimated $481.
  • Manchester Capital Management first reported a position in Medpace in Q3 2021 and held it in 14 quarters.
  • Manchester Capital Management's Medpace position peaked at $209K in Q2 2024.
  • 698 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Manchester Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.